(Q39009188)

8 September 2017

title

Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer (English)

1 reference

8 September 2017

0 references

1 reference

Yanbin Zhao

1

1 reference

8 September 2017

Hongbin Wang

2

1 reference

8 September 2017

Xiuli Li

3

1 reference

8 September 2017

Mengru Cao

4

1 reference

8 September 2017

Hailing Lu

5

1 reference

8 September 2017

Qingwei Meng

6

1 reference

8 September 2017

Hui Pang

7

1 reference

8 September 2017

Hailin Li

8

1 reference

8 September 2017

Christina Nadolny

9

1 reference

8 September 2017

Xiaoqun Dong

10

1 reference

8 September 2017

Li Cai

11

1 reference

8 September 2017

publication date

1 November 2014

1 reference

Journal of Cellular Physiology

8 September 2017

published in

1 reference

8 September 2017

volume

229

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

1855-1862

1 reference

AT1 receptors activation enhances the expression of MMP-2, MMP-13 and VEGF but not MMP-9 in B16F10 melanoma cells

8 September 2017

cites work

1 reference

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.

21 January 2018

1 reference

Integrin beta1 upregulation in MCF-7 breast cancer cells by angiotensin II.

21 January 2018

1 reference

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

21 January 2018

1 reference

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer

21 January 2018

1 reference

Cellular survival: a play in three Akts

21 January 2018

1 reference

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer.

21 January 2018

1 reference

Angiotensin receptors: a new role in cancer?

21 January 2018

1 reference

21 January 2018

1 reference

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

The renin-angiotensin system and cancer: old dog, new tricks.

21 January 2018

1 reference

Trends in cancer mortality in China: an update

21 January 2018

1 reference

Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells

21 January 2018

1 reference

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

21 January 2018

1 reference

Angiotensin II augmented migration and invasion of choriocarcinoma cells involves PI3K activation through the AT1 receptor

21 January 2018

1 reference

The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

21 January 2018

1 reference

Induction of NF-kappaB by the Akt/PKB kinase

21 January 2018

1 reference

Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.

21 January 2018

1 reference

Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin

21 January 2018

1 reference

Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.

21 January 2018

1 reference

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

21 January 2018

1 reference

Anti-angiotensin and hypoglycemic treatments suppress liver metastasis of colon cancer cells

21 January 2018

1 reference

Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer

21 January 2018

1 reference

The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion

21 January 2018

1 reference

Angiotensin II facilitates breast cancer cell migration and metastasis

21 January 2018

1 reference

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

21 January 2018

1 reference

Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion

21 January 2018

1 reference

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

21 January 2018

1 reference

Engagement of renin-angiotensin system in prostate cancer

21 January 2018

1 reference

Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways

21 January 2018

1 reference

Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase/Akt signaling in human breast cancer cells

21 January 2018

1 reference

Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway

21 January 2018

1 reference

Matrix metalloproteinases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24639

1 reference

8 September 2017

1 reference